Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)

Position Papers1 September 1985Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)A Report of the French-American-British Cooperative GroupJOHN M. BENNETT, M.D., DANIEL CATOVSKY, M.D., MARIE-THERESE DANIEL, M.D., GEORGES FLANDRIN, M.D., DAVID A. G. GALTON, M.D., HARVEY R. GRALNICK, M.D., CLAUDE SULTAN, M.D.JOHN M. BENNETT, M.D.Search for more papers by this author, DANIEL CATOVSKY, M.D.Search for more papers by this author, MARIE-THERESE DANIEL, M.D.Search for more papers by this author, GEORGES FLANDRIN, M.D.Search for more papers by this author, DAVID A. G. GALTON, M.D.Search for more papers by this author, HARVEY R. GRALNICK, M.D.Search for more papers by this author, CLAUDE SULTAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-103-3-460 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn the past, the French-American-British (FAB) Cooperative Group has classified acute myeloid leukemia on the basis of the morphologic features and number of blast cells, the percentage of maturing myeloid cells, and the percentage of the monocytic component in the bone marrow (1). We have previously considered peripheral blood findings only for the diagnosis of the M4 class of leukemia, that is, the monocytic component; in other forms of leukemia (types L1 to L3, M1 to M3, and M5 to M6), examination of the peripheral blood, though often important in arriving at a diagnosis, was not essential in the classification of the type of leukemia.We have examined the peripheral blood films, bone marrow smears, and bone marrow biopsies of 16 well-documented cases of acute megakaryoblastic leukemia. In the diagnosis of megakaryoblastic leukemia, (known as M7), we depart from our previous procedure because, at times, bone marrow smears obtained by aspiration may not be adequate to make a diagnosis of acute leukemia or aspiration may fail due to increased bone marrow fibrosis. In these instances, the bone marrow cytologic findings cannot be used for classification, and peripheral blood films must be examined....References1. BENNETTCATOVSKYDANIEL JDM. Proposals for the classification of acute leukemia. Br J Haematol. 1976;33:451-8. CrossrefMedlineGoogle Scholar2. DEN OTTOLANDERVELDEBREDERRO GTP. Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases. Br J Haematol. 1979;42:9-20. CrossrefMedlineGoogle Scholar3. YAMENGLISHJANCKILAZIESMERLI LMASC. Immunocytochemical characterization of human blood cells. Am J Clin Pathol. 1983;80:314-21. CrossrefMedlineGoogle Scholar4. MIRCHANDANIPALUTKE IM. Acute megakaryoblastic leukemia. Cancer. 1983;50:2866-72. CrossrefGoogle Scholar5. CHANBRYNESKIM WRT. Acute megakaryoblastic leukemia in early childhood. Blood. 1983;62:92-8. CrossrefMedlineGoogle Scholar6. SARIBANOLIVERCORASH ECL. Acute megakaryoblastic leukemia in childhood. Cancer. 1984;54:1423-8. CrossrefMedlineGoogle Scholar7. EFRATINIRYAARIBERREBIKAPLANDVILANSKI PEAAHA. Myeloproliferative disorders terminating in acute micromegakaryoblastic leukaemia. Br J Haematol. 1979;43:79-86. CrossrefMedlineGoogle Scholar8. BRETON-GORIUSDANIELFLANDRINDENOEL JMGG. Fine structure and peroxidase activity of circulating micromegakaryoblasts and platelets in a case of acute myelofibrosis. Br J Haematol. 1973;25:331-9. CrossrefMedlineGoogle Scholar9. BAINCATOVSKYO'BRIEN BDM. Megakaryoblastic leukemia presenting as acute myelofibrosis—a study of four cases with the platelet-peroxidase reaction. Blood. 1981;58:206-13. CrossrefMedlineGoogle Scholar10. BRETON-GORIUSREYESVERNANTTULLIEZDREYFUL JFJMB. The blast crisis of chronic granulocytic leukemia: megakaryoblastic nature of cells revealed by the presence of platelet-peroxidase—a cytochemical ultrastructural study. Br J Haematol. 1978;39:295-303. CrossrefMedlineGoogle Scholar11. VINCITABILIODESCHAMPS GAJ. Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol. 1984;56:589-605. CrossrefMedlineGoogle Scholar12. TABILIOVAINCHENCKERVAN HAECKE AWD. Immunological characterization of the leukemic megakaryocytic line at light and electron microscopic levels. Leuk Res. 1984;8:769-81. CrossrefMedlineGoogle Scholar13. BRETON-GORIUSVAN HAEKEPRYZWANSKY JDK. Simultaneous detection of membrane markers with monoclonal antibodies and peroxidatic activities in leukaemia: ultrastructural analysis using a new method of fixation preserving the platelet peroxidase. Br J Haematol. 1984;58:447-58. CrossrefMedlineGoogle Scholar14. RABELLINOLEVENELEUNGNACHMAN ERLR. Human megakaryocytes: II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med. 1981;154:88-100. CrossrefMedlineGoogle Scholar15. VAINCHENCKERDESCHAMPSBASTIN WJJ. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in-vivo cells from normal and leukemic patients. Blood. 1982;59:514-21. CrossrefMedlineGoogle Scholar16. BEVANROSEGREAVES DMM. Leukaemia of platelet precursors: diverse features in four cases. Br J Haematol. 1982;51:147-64. CrossrefMedlineGoogle Scholar17. TETTEROOLANSDORPLEEKSMAVON DEM BORNE PPOA. Monoclonal antibodies against human platelet glycoprotein IIIa. Br J Haematol. 1983;55:509-22. CrossrefMedlineGoogle Scholar18. ZOLAMCNAMARABECKMAN HPI. Monoclonal antibodies against antigens of the human platelet surface: preparation and properties. Pathology. 1984;16:73-8. CrossrefMedlineGoogle Scholar19. HUANGLINICHOLSYOUNGKATZMANN MCWJJ. Acute leukemia with megakaryocytic differentiation: a study of 12 cases identified immunocytochemically. Blood. 1984;64:427-39. CrossrefMedlineGoogle Scholar20. SAN MIGUELTAVARESCASTROMATUTES JDJE. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia: II. Studies with monoclonal antibodies and terminal transferase. Br J Haematol. 1985;59:297-311. CrossrefMedlineGoogle Scholar21. INNESMILLSWALKER DSG. Megakaryocytic leukemia: identification utilizing anti-factor VIII immunoperoxidase. Am J Clin Pathol. 1982;77:107-14. CrossrefMedlineGoogle Scholar22. COSSONDESPRESGAZENGELBRETON-GORIUSPRIEURJOSSO APCJMF. Syndrome leucemique singulier chex un nouveau-ne trisomique 21: proliferation megacaryocyto-plaquettaire; syndrome de coagulation intravasculaire diffuse. Nouv Rev Fr Hematol. 1974;14:181-98. MedlineGoogle Scholar23. EVANS D. Acute myelofibrosis in children with Down's syndrome. Arch Dis Child. 1975;50:458-62. CrossrefMedlineGoogle Scholar24. PUI-C-HWILLIAMSSCARBOROUGHJACKSONPRICEMURPHY DVCRS. Acute megakaryoblastic leukaemia associated with intrinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy. Br J Haematol. 1982;50:191-200. CrossrefMedlineGoogle Scholar25. SULTANSIGAUXIMBERTREYES CFMF. Acute myelodysplasia with myelofibrosis: a report of eight cases. Br J Haematol. 1981;49:11-6. CrossrefMedlineGoogle Scholar26. CASTRO-MALASPINARABELLINOYENNACHMANMOORE HEARM. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood. 1981;57:781-7. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Rochester, New York; London England Paris and Creteil France Bethesda, Maryland▸From the University of Rochester Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York; Medical Research Council Leukaemia Unit, Royal Postgraduate Medical School, London, England; Institut de Recherches sur les Leucemies et les Maladies du Sang, Hopital Saint-Louis, Paris, France; Hematology Service, National Institutes of Health, Bethesda, Maryland; and Service Central d'Hematologie-Immunologie, Hopital Henri Mondor, Creteil, France. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRegulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemiaCoexistence of myelodysplastic syndrome and acute megakaryoblastic leukemia: An aggressive diseaseReferencesOutcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in ChinaCell signaling pathways as molecular targets to eliminate AML stem cellsCharacterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation StatusGenomic Landscape and Clonal Evolution of AMLNormal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impactMass spectrometry imaging in lipid and proteomic profiling: an emerging tool for cancer diagnosisCytogenetics/cytogenomicsDown syndrome presenting with different hematological manifestations: A case series of four casesAssociations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysisImidazo[1,2-b]pyrazole-7-carboxamides Induce Apoptosis in Human Leukemia Cells at Nanomolar ConcentrationsThe Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic LeukemiaClinical challenges in de novo pediatric acute myeloid leukemiaPhosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemiaAcute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood TransplantationGenotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004Clinical and prognostic significance of eosinophilia and inv(16)/t(16;16) in pediatric acute myelomonocytic leukemia (AML-M4)Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of HematologyPediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic CooperationsTherapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trialDogs with Acute Myeloid Leukemia Have Clonal Rearrangements in T and B Cell ReceptorsThe Nature of Leukaemia, Cytology, Cytochemistry and the Morphological Classification of Acute LeukaemiaAcute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid LeukemiaAcute Leukemias of Granulocytic, Erythroid, and Megakaryocytic LineagesImmunophenotype Discovery, Hierarchical Organization, and Template-Based Classification of Flow Cytometry SamplesEvaluation of D-dimer and lactate dehydrogenase plasma levels in patients with relapsed acute leukemiaQuality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasiaPHA-Induced Peripheral Blood Cytogenetics and Molecular Anslysis : a Valid Diagnostic and Follow-up Modality For Acute Primyelocytic Leukemia Patients Treated With ATRA and/or Arsenic Tri-oxideMolecular genetics of paediatric acute myeloid leukaemiaCyclophosphamide combined with mitoxantrone and cytarabine is an effective salvage regimen for patients with acute myeloid leukemia who experienced primary induction failure or relapseAcute Leukemias of Granulocytic, Erythroid, and Megakaryocytic LineagesAcute megakaryocytic leukemia: What have we learnedImproved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialHousehold pesticide exposure and the risk of childhood acute leukemia in Shanghai, ChinaAcute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive MimicsPrognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemiaAcute myeloid leukemiaPediatric AML: From Biology to Clinical ManagementDisorders of White CellsMinimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresisAcute Myeloid LeukaemiaBlast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndromeClinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocationOverview of Cancer Stem Cells (CSCs) and Mechanisms of Their Regulation: Implications for Cancer TherapySignificance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patientsDevelopment of treatment and clinical results in childhood acute myeloid leukemia in the Czech RepublicDiagnosis and Treatment of Childhood Acute Myeloid LeukemiaThe Myelodysplastic SyndromesPlatelet Morphology AnalysisA de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpointsMobilization of CD34 + CD38 - hematopoietic stem cells after priming in acute myeloid leukemiaComparison of Autologous Hematopoietic Cell Transplantation and Chemotherapy as Postremission Treatment in Non-M3 Acute Myeloid Leukemia in First Complete RemissionManagement of AML: Who do we really cure?Historical perspectives on myelodysplastic syndromesUse of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog *Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorderFavorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trialCurrent treatment of acute myeloid leukaemia in adultsA scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemiaCNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML-BFM98 and 2004De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosomeComparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 studyA single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia—evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patientsAntigensDiseasesDiagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review studyThe Nature of Leukaemia, Cytology, Cytochemistry and the FAB Classification of Acute LeukaemiaAcute Myeloid LeukemiaEpidemiology of Acute Childhood LeukemiaAcute Myeloid LeukemiaLeukocytic DisordersAcute Myeloid Leukemia With Myelodysplasia-Related Changes: A New DefinitionGene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirusAcute Myeloid LeukemiaCytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AMLPrognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesUnique clinical and biological features of leukemia in Down syndrome childrenAcute Myeloid Leukemias with Recurrent Cytogenetic AbnormalitiesChromosomal Abnormalities in Selected Hematopoietic Malignancies Detected by Conventional and Molecular Cytogenetics: Diagnostic and Prognostic SignificanceCancer among Persons with Down SyndromeDeterminants of urinary 8-hydroxy-2′-deoxyguanosine in Chinese children with acute leukemiaMinimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AMLAcute megakaryoblastic leukemia in a child with the MLL-AF4 fusion geneAcute Megakaryocytic Leukaemia (AMKL)-like Disease in a Cynomolgus Monkey (Macaca fascicularis)Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemiaMyeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease in ChildrenBone MarrowExpression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrowPreliminary Results of Introducing the Method Multiparameter Flow Cytometry in Patients with Acute Leukemia in the Republic of MacedoniaMegakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemiaReceptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemiaTumors of the Hemolymphatic SystemPrognostic significance of myeloperoxidase expression in childhood acute myeloid leukemiaAcute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndromeMLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patientsSignificance of age in acute myeloid leukemia patients younger than 30 yearsCooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samplesLoss of the extra chromosome 21 in a patient with Down syndrome and myelodysplasiaThe Development of a Novel Protocol for the Treatment of De Novo Childhood Acute Myeloid Leukemia in a Single Institution in TaiwanLeukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhageFrequent but nonrandom expression of lymphoid markers on de novo childhood acute myeloid leukemiaCytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemiaCD34 + , CD41 + acute megakaryoblastic leukemia in a dogComparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: Report from the Children's Oncology GroupPostremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trialStandards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEffect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) GroupAcute myeloid leukemia (AML-M2) with t(5;11)(q35;q13) and normal expression of cyclin D1FAB and beyondGuidelines on the management of acute myeloid leukaemia in adultsLess Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98Residual Disease Monitoring in Childhood Acute Myeloid Leukemia by Multiparameter Flow Cytometry: The MRD-AML-BFM Study GroupClinical, Histopathological and Immunohistochemical Findings in a Case of Megakaryoblastic Leukemia in a DogGATA1 mutations in acute leukemia in children with Down syndromeNucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease EvolutionAutotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant ResearchK-ras mutations and N-ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangementsAdvances in the pathologic diagnosis and biology of acute myeloid leukemiaAdult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer CenterAkute myeloische Leukämie (AML)Akute lymphatische Leukämie (ALL)Akute myeloische LeukämieDifferentiation Induction in Leukemia and LymphomaImproved treatment results for childhood acute myeloid leukemia in TaiwanEvaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemiaTreatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocolsTreatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trialsTreatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsModern diagnostics in acute leukemiasMLL–MLLT10 fusion gene in pediatric acute megakaryoblastic leukemiaTreatment of childhood acute myeloid leukemiaQuantitation of Minimal Residual Disease in Acute Myeloid Leukemia by Tryptase Monitoring Identifies a Group of Patients with a High Risk of RelapseThe risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatmentAML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensityBenzene and the hemopoietic stem cellAcute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemiaTreatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer – An updateCEBPα mutations in childhood acute myeloid leukemiaOrigins of leukaemia in children with Down syndromeAcute myeloid leukemia in adultsMalignant hematopoietic cell lines: in vitro models for the study of erythroleukemiaGene expression profiling of pediatric acute myelogenous leukemiaAcute Myeloid Leukemia (AML)—Cytogenetic Detection of Selected Recurrent Chromosomal AbnormalitiesLife expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaCytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridizationEarly Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndromeClassical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in IsraelOccurrence of a variant Philadelphia translocation, t(10;22), in de novo acute megakaryoblastic leukemiaDifferentiation of Acute Myeloid Leukemia from B- and T-Lineage Acute Lymphoid Leukemias by Real-Time Quantitative Reverse Transcription-PCR of Lineage Marker mRNAsAcute Panmyelosis with MyelofibrosisImmunophenotyping of acute leukemias and myelodysplastic syndromesThe therapy of relapsed acute leukaemia in adultsFatal Familial Infantile MyelofibrosisUsefulness of CD9 detection in the diagnosis of acute megakaryoblastic leukemiaHematologic Manifestations of Trisomy 21Pilot Study of Idarubicin-Based Intensive-Timing Induction Therapy for Children With Previously Untreated Acute Myeloid Leukemia: Children's Cancer Group Study 2941Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaClassification systems for acute and chronic leukaemiasThe prognostic significance of antigen expression in leukaemiaAssessment of Differences in Patient Populations Selected for or Excluded From Participation in Clinical Phase III Acute Myelogenous Leukemia TrialsAcute myeloid leukemia in the older patientCytogenetic findings in adult de novo acute myeloid leukaemia. A population-based study of 303/337 patientsAML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML casesIncreased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891Treatment concepts for elderly patients with acute myeloid leukemiaThe percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotypeBiology, clinical, and hematologic features of acute megakaryoblastic leukemia in childrenPrognostic Significance of CD7+CD56+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndromeFLT3-TKD mutation in childhood acute myeloid leukemiaCytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001Immunohistochemical Detection of VEGF in the Bone Marrow of Patients With Acute Myeloid LeukemiaTranscriptional regulation of the cystathionine-β-synthase gene in Down syndrome and non–Down syndrome megakaryocytic leukemia cell linesMegakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotypeMorphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group StudiesAkute myeloische LeukämienFLT3 Length Mutations and MLL-Duplications in AML: Correlation to Cytogenetics, FAB-Subtype,and PrognosisCytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 studyAcute Myelogenous Leukemia with t(8;21)—Identification of a Specific ImmunophenotypeAcute myelocytic leukemia (M0) in an elderly patient with relapsed granulocytic sarcoma (M7) of bone during the second period of complete remission 5 years after onsetUse of the Cell-Dyn 3500 to Predict Leukemic Cell Lineage in Peripheral Blood of Dogs and CatsEffects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitroTherapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: An underemphasized clinical problemSkeletal Manifestations of Pediatric Acute Megakaryoblastic LeukemiaAcute megakaryoblastic leukemia: experience of GIMEMA trialsLeukemiasProtocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Bone MarrowAcute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patientsAcute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentationMegakaryocytic blast crisis as a first presentation of chronic myeloid leukemiaAntigen expression patterns reflecting genotype of acute leukemiasInduction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 studyClinical relevance of internal tandem duplication of theFLT3 gene in childhood acute myeloid leukemiaMutations of theAML1 gene in acute myeloid leukemia of FAB types M0 and M7Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiersAcute leukemiaMegakaryoblastic transformation of chronic myelomonocytic leukemia presenting with severe bone painThe Immunophenotype of 325 Adult Acute LeukemiasClinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23Aplicación de la citometría de flujo al diagnóstico y seguimiento inmunofenotípico de las leucemias agudasMutations in the p53 Gene in Acute Myeloid Leukemia Patients Correlate with Poor PrognosisTryptase a Novel Biochemical Marker of Acute Myeloid LeukemiaClinical relevance of in vitro chemoresistance in childhood acute myeloid leukemiaDistinctive Multidrug Sensitivity and Outcome of Acute Erythroblastic and Megakaryoblastic Leukemia in Children With Down SyndromePrognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemiaFlow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemiaSmoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose–response relationsMyelodysplasia with fibrosis: a distinct entity?The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphologyExpression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid